HSPA5 and central nervous system cancer: Other nanoparticles coated with VAP (a D-peptide ligand of GRP78) [116] and RI-VAP (a specific ligand of cell surface GRP78) [117] were shown to effectively target glioblastoma and glioma, respectively.